Patent Act P-4
Section 80, as amended by S.C. 2017, c. 6, s. 47
- Earlier version
- In force until June 29, 2021
- Later version
- In force since June 30, 2021 (version in force)
Text deletedText added
Marginal note:Pricing information, etc., required by regulations
80 (1) A Start of deletion patentee of End of deletionStart of insertion rights holder for End of insertionan invention pertaining to a medicine shall, as required by and in accordance with the regulations, provide the Board with Start of deletion such End of deletionStart of insertion the End of insertioninformation and documents Start of deletion as End of deletionStart of insertion that End of insertionthe regulations may specify respecting
(a) the identity of the medicine;
(b) the price at which the medicine is being or has been sold in any market in Canada and elsewhere;
(c) the costs of making and marketing the medicine, Start of deletion where End of deletionStart of insertion if End of insertionthat information is available to the Start of deletion patentee End of deletionStart of insertion rights holder End of insertionin Canada or is within the knowledge or control of the Start of deletion patentee End of deletionStart of insertion rights holder End of insertion;
(e) any other related matters.
Start of deletion Idem End of deletionStart of insertion Former rights holder End of insertion
(2) Subject to subsection (3), a person who is a former Start of deletion patentee of End of deletionStart of insertion rights holder for End of insertionan invention pertaining to a medicine shall, as required by and in accordance with the regulations, provide the Board with Start of deletion such End of deletionStart of insertion the End of insertioninformation and documents Start of deletion as End of deletionStart of insertion that End of insertionthe regulations may specify respecting
(a) the identity of the medicine;
(b) the price at which the medicine was sold in any market in Canada and elsewhere during the period in which the person was a Start of deletion patentee of End of deletionStart of insertion rights holder for End of insertionthe invention;
(c) the costs of making and marketing the medicine produced during that period, whether incurred before or after the patent was issued Start of insertion or the certificate of supplementary protection took effect End of insertion, Start of deletion where End of deletionStart of insertion if End of insertionthat information is available to the person in Canada or is within the knowledge or control of the person;
(e) any other related matters.
Marginal note:Limitation
(3) Subsection (2) does not apply to a person who has notStart of insertion , for a period of three or more years, End of insertionbeen entitled to the benefit of the patent Start of insertion or certificate of supplementary protection, as the case may be, End of insertionor to exercise any rights in relation to the patent Start of deletion for a period of three End of deletionor Start of deletion more years End of deletionStart of insertion certificate End of insertion.
Read the provisionHistory of the ActShow the text in English and French, side by side
Unofficial reproduction of the consolidated text published by the Department of Justice Canada, permitted by the Reproduction of Federal Law Order. Only the official text is authoritative.